4th Quarter - Report

UPSTREAM CONSULTING for RARE ACCESS ACTION PROJECT

Firm
Client
Income
$12,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Reimbursement coverage by Medicaid and Medicare for rare disease therapies.

LobbyistCovered position, as disclosed
MCCLAIN C HADDOW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Reimbursement coverage for rare disease therapies.

LobbyistCovered position, as disclosed
MCCLAIN C HADDOW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Promote the importance of federal health programs to facilitate patient access to rare disease therapies.

LobbyistCovered position, as disclosed
MCCLAIN C HADDOW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Conviction disclosures

Disclosed by the filer under the Act's requirement to report certain convictions of its lobbyists.

LobbyistDateDescription
MCCLAIN HADDOW Sep 15, 1987 9/15/1987, U.S. District Court, 18 U.S.C. Section 208(a), conflict of interest (2 counts)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.